Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities (Q4670477): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
Set profile property. |
||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Revision as of 16:50, 5 March 2024
scientific article; zbMATH DE number 2160436
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities |
scientific article; zbMATH DE number 2160436 |
Statements
Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities (English)
0 references
22 April 2005
0 references
continual reassessment method
0 references
dose limiting
0 references
late-onset toxicities
0 references
likelihood-based design
0 references
phase I trial
0 references
time-to-event
0 references
